Onderneming Lipella Pharmaceuticals Inc.
Aandelen
LIPO
US53630L1008
Biotechnologie & Medisch Onderzoek
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,7551 USD | -0,96% | +3,16% | -25,97% |
Vakgebied
Aantal werknemers: 6
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Biopharmaceuticals
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +144,15% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +144,15% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 67 | 01-01-05 | |
Jonathan Kaufman
CEO | Chief Executive Officer | 58 | 01-01-05 |
Douglas Johnston
DFI | Director of Finance/CFO | 40 | 01-10-21 |
Janet Okonski
CTO | Chief Tech/Sci/R&D Officer | - | 01-08-21 |
Joseph Janicki
CTO | Chief Tech/Sci/R&D Officer | - | - |
Michelle Gruber
COO | Chief Operating Officer | - | 01-01-09 |
Katie Johnston
AUD | Comptroller/Controller/Auditor | - | - |
Allison Houck
PRN | Corporate Officer/Principal | - | - |
Tomohiro Ueda
PRN | Corporate Officer/Principal | - | - |
Robert Moldwin
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jonathan Kaufman
CEO | Chief Executive Officer | 58 | 01-01-05 |
Founder | 67 | 01-01-05 | |
Byong Kim
BRD | Director/Board Member | 54 | 01-03-22 |
Ryan Pruchnic
BRD | Director/Board Member | 50 | 01-09-21 |
Naoki Yoshimura
BRD | Director/Board Member | 67 | 01-09-21 |
Daniel Cohen
BRD | Director/Board Member | 60 | 21-03-23 |
Lori Birder
BRD | Director/Board Member | 64 | 17-06-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 7 605 636 | 4 530 361 ( 59,57 %) | 0 | 59,57 % |
Bedrijfsgegevens
Lipella Pharmaceuticals, Inc.
7800 Susquehanna Street Suite 505
15208, Pittsburgh
+412-901-0315
http://www.lipella.comSector
Herzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-25,97% | 5,8 mln. | |
+9,35% | 114 mld. | |
+11,38% | 104 mld. | |
-13,72% | 22,41 mld. | |
-1,05% | 22,28 mld. | |
-5,29% | 19,07 mld. | |
-38,29% | 18 mld. | |
-3,99% | 17,89 mld. | |
+7,68% | 14,28 mld. | |
+34,50% | 12,55 mld. |
- Beurs
- Aandelen
- Koers LIPO
- Onderneming Lipella Pharmaceuticals Inc.